Statewide
Washington State Department of Health
The current listed document is more than 24 months old and may be outdated.
Drugs and doses18
A–C Acetaminophen, Activated Charcoal, Albuterol, Albuterol-Ipratropium, Aspirin, Atropine, Cetirizine7
Acetaminophen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Fever | adult | 500–1000 mg | PO/PR | not captured | standing | pages 59, 98 |
| Fever | peds | 15 mg/kg | PO/PR | not captured | standing | pages 59, 98 |
| Mild to moderate pain | adult | 500–1000 mg | PO | not captured | standing | pages 52, 98 |
| Mild to moderate pain | peds | 15 mg/kg | PO | not captured | standing | pages 52, 98 |
Activated Charcoal
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 50 g | PO | not captured | standing | pages 50, 51, 97 |
| Other | peds | 1 g/kg | PO | not captured | standing | pages 50, 51, 97 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 2.5 mg | NEB | not captured | standing | page 27 |
| Allergic reaction | peds | 2.5–5 mg | NEB | not captured | standing | page 27 |
| Asthma / bronchospasm | adult | 2.5 mg | NEB | not captured | standing | page 56 |
| Asthma / bronchospasm | peds | 2.5 mg | NEB | not captured | standing | page 56 |
Albuterol-Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 3 mL | NEB | not captured | standing | page 27 |
| Allergic reaction | peds | 3 mL | NEB | not captured | standing | page 27 |
| Asthma / bronchospasm | adult | 3 mL | NEB | not captured | standing | page 27 |
| Asthma / bronchospasm | adult | 3 mL | NEB | not captured | standing | pages 30, 106 |
| Asthma / bronchospasm | peds | 3 mL | NEB | not captured | standing | page 27 |
| Asthma / bronchospasm | peds | 3 mL | NEB | not captured | standing | pages 30, 106 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 324 mg | PO | not captured | standing | pages 35, 100 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nerve agent exposure | adult | 2 mg | IM | not captured | standing | page 101 |
| Organophosphate poisoning | adult | 2 mg | IM | not captured | standing | pages 50, 101 |
Cetirizine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 10 mg | PO | not captured | standing | pages 27, 102 |
| Allergic reaction | peds | 2.5 mg | PO | not captured | standing | pages 27, 102 |
D–F Dextrose, Diphenhydramine, Epinephrine3
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperglycemia / DKA | adult | 1 L | IV | not captured | standing | page 36 |
| Hyperglycemia / DKA | peds | 10 mL/kg | IV | not captured | standing | page 36 |
| Hypoglycemia | adult | 25 g | IV/IO | not captured | standing | pages 36, 104 |
| Hypoglycemia | peds | 2 mL/kg | IV/IO | not captured | standing | pages 36, 104 |
| Hypoglycemia | peds | 5 mL/kg | IV/IO | not captured | standing | pages 36, 104 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 25–50 mg | IV/IM | not captured | standing | pages 27, 105 |
| Allergic reaction | adult | 50 mg | PO | not captured | standing | pages 27, 105 |
| Allergic reaction | peds | 1 mg/kg | PO | not captured | standing | pages 27, 105 |
| Allergic reaction | peds | 1–2 mg/kg | IV/IM | not captured | standing | pages 27, 105 |
| Dystonic reaction | adult | 12.5–50 mg | IV/IM | not captured | standing | pages 51, 105 |
| Dystonic reaction | peds | 1 mg/kg | IV/IM | not captured | standing | pages 51, 105 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.3 mg | IM | not captured | standing | pages 27, 107 |
| Anaphylaxis | peds | 0.15 mg | IM | not captured | standing | pages 27, 107 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | pages 31, 33, 107 |
| Cardiac arrest | peds | 0.01 mg/kg | IV/IO | not captured | standing | pages 31, 33, 107 |
G–L Glucagon, Ibuprofen, Ipratropium3
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 1 mg | IM/IN | not captured | standing | page 36 |
Ibuprofen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Fever | peds | 10 mg/kg | PO | not captured | standing | pages 59, 108 |
| Mild to moderate pain | adult | 400–800 mg | PO | not captured | standing | pages 52, 108 |
| Mild to moderate pain | peds | 10 mg/kg | PO | not captured | standing | pages 52, 108 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 0.5 mg | NEB | not captured | standing | pages 27, 56, 109 |
| Allergic reaction | peds | 0.25 mg | NEB | not captured | standing | pages 27, 56, 109 |
| Asthma / bronchospasm | adult | 0.5 mg | NEB | not captured | standing | pages 56, 106, 109 |
| Asthma / bronchospasm | peds | 0.25 mg | NEB | not captured | standing | pages 56, 106, 109 |
| Organophosphate poisoning | adult | 0.5 mg | NEB | not captured | standing | page 109 |
M–O Naloxone, Nitroglycerin, Ondansetron, Oral Glucose4
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Opioid overdose | adult | 0.4–2 mg | IV/IO | not captured | standing | pages 51, 110 |
| Opioid overdose | adult | 0.4–4 mg | IN | not captured | standing | pages 50, 110 |
| Opioid overdose | adult | 0.4–4 mg | IM | not captured | standing | pages 51, 110 |
| Opioid overdose | peds | 0.1 mg/kg | IN | not captured | standing | pages 50, 110 |
| Opioid overdose | peds | 0.1 mg/kg | IM | not captured | standing | pages 51, 110 |
| Opioid overdose | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 51, 110 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.4 mg | SL | not captured | standing | pages 35, 111 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 4 mg | IV/IM | not captured | standing | pages 45, 113 |
| Nausea / vomiting | adult | 4–8 mg | SL/ODT | not captured | standing | pages 45, 113 |
| Nausea / vomiting | peds | 0.15 mg/kg | IV/IM | not captured | standing | pages 45, 113 |
| Nausea / vomiting | peds | 2–4 mg | SL/ODT | not captured | standing | pages 45, 113 |
Oral Glucose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 25 g | PO | not captured | standing | pages 36, 103 |
| Hypoglycemia | peds | 0.5–1 g/kg | PO | not captured | standing | pages 36, 103 |
P–R Pralidoxime1
Pralidoxime
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nerve agent exposure | adult | 600 mg | IM | not captured | standing | page 116 |
| Organophosphate poisoning | adult | 600 mg | IM | not captured | standing | pages 50, 116 |
Cite this
Washington State Department of Health, United States EMS Protocol Census. 60 dose entries, effective 2024-08-01.
https://protoquiz.com/census/agencies/washington-state-department-of-health/
The census is free and not for sale. Only public agencies are named.